| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | TRUL | Subordinate Voting Shares | 437,158 | 26 Feb 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | TRUL | Multiple Voting Shares | 26 Feb 2025 | Subordinate Voting Shares | 2,263,500 | $0.000000 | By Trust | F2, F3 | ||||||
| holding | TRUL | Multiple Voting Shares | 26 Feb 2025 | Subordinate Voting Shares | 2,263,600 | $0.000000 | By Trust | F2, F4 | ||||||
| holding | TRUL | Stock Option (Right to Buy) | 26 Feb 2025 | Subordinate Voting Shares | 19,358 | $33.42 | Direct | F5 | ||||||
| holding | TRUL | Stock Option (Right to Buy) | 26 Feb 2025 | Subordinate Voting Shares | 67,902 | $10.00 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | The amount of securities beneficially owned in column 2 includes a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp subordinate voting share. The reporting person was granted 37,500 RSUs on March 8, 2024, subject to 2-year vesting. The RSUs will vest 50% on December 1, 2025 and 50% on December 1, 2026. |
| F2 | Multiple Voting Shares are convertible into Subordinate Voting Shares on a one-for-100 basis. Multiple Voting Shares are convertible at any time and have no expiration date. |
| F3 | Shares are held by the JASON B PERNELL TR KFP IRREVOCABLE TRUST DTD 03/02/2020. |
| F4 | Shares are held by the KATHRYN FIELD PERNELL & TY ROOFNER TR JBP 2020 IRREVOCABLE TRUST DTD 01/06/2020. |
| F5 | The options were granted on January 4, 2021. As of December 31, 2023, all of the options were fully vested and exercisable. |
| F6 | The options were granted on March 8, 2024, and vest 33% per year in equal installments, starting on December 1 of the grant year. One third of the options vested and became exercisable on December 1, 2024; one third of the options will vest and become exercisable on December 1, 2025; and one third of the options will vest and become exercisable on December 1, 2026. |